US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GT Biopharma Inc.

0.9206

+0.190826.14%

Pre-market: 0.7196-0.2010-21.83%07:50 EST

Volume:13.26M

Turnover:12.46M

Market Cap:9.79M

PE:-0.23

High:1.15

Open:0.7448

Low:0.7075

Close:0.7298

52wk High:4.10

52wk Low:0.5400

Shares:10.64M

Float Shares:9.26M

Volume Ratio:21.19

T/O Rate:143.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.9434

EPS(LYR):-6.9370

ROE:-181.99%

ROA:-82.45%

PB:3.42

PE(LYR):-0.13

Loading ...

Overview Company News Filings

GT Biopharma Inc: Holds $2.6M Cash and Cash Equivalents as of Sept 30, Funding Operations Through Q1 2026

THOMSON REUTERS

GT Biopharma Inc: Anticipates Submission of Ind Application for Gtb-5550 in Late December 2025 or in January 2026

THOMSON REUTERS

GT Biopharma files to sell 14.59M shares of common stock for holders

BRIEF-GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

GT Biopharma Provides Enrollment Update on Gtb-3650 Phase 1 Trial in Patients With Relapsed or Refractory (R/R) Cd33 Expressing Hematologic Malignancies

THOMSON REUTERS

GT Biopharma Inc - Screening Patients for Cohort 4, Dosing to Start Soon

THOMSON REUTERS

GT Biopharma Inc - Advances to Cohort 4 With 10 Ug/Kg/Day Dose

THOMSON REUTERS

GT Biopharma Inc - Next Update Expected in Q1 2026 With Dose Escalation

THOMSON REUTERS

GT Biopharma Provides Enrollment Update on Gtb-3650 Phase 1 Trial in Patients With Relapsed or Refractory (R/R) Cd33 Expressing Hematologic Malignancies

THOMSON REUTERS

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

GT Biopharma to Participate in the Centurion One Capital 3rd Annual Bahamas Summit

GT Biopharma Preferred Shareholders Waive Redemption Rights on Series L Convertible Preferred Stock

GT Biopharma Inc. Announces Waiver of Redemption Rights for Series L Preferred Stockholders

GT Biopharma Inc. Renews CEO Michael Breen's Contract for Additional Two Years

GT Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary

GT Biopharma Q2 EPS $(0.55) Beats $(0.68) Estimate

GT Biopharma Inc: Q2 Net Loss About $1.4 Mln

THOMSON REUTERS

GT Biopharma Reports Second Quarter 2025 Financial Results

GT Biopharma Inc - to Release Initial Phase 1 Results in 2025

THOMSON REUTERS

GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GTBP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GTBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GTBP\",,,,,undefined,":{"symbol":"GTBP","market":"US","secType":"STK","nameCN":"GT Biopharma Inc.","latestPrice":0.9206,"timestamp":1763154000000,"preClose":0.7298,"halted":0,"volume":13255009,"hourTrading":{"tag":"盘前","latestPrice":0.7196,"preClose":0.9206,"latestTime":"07:50 EST","volume":19440,"amount":13795.432703999999,"timestamp":1763383838813},"delay":0,"floatShares":9262500,"shares":10636135,"eps":-3.943378,"marketStatus":"Pre-Mkt","change":0.1908,"latestTime":"11-17 07:53:59 EST","open":0.7448,"high":1.15,"low":0.707499,"amount":12455737.2593036,"amplitude":0.606332,"askPrice":0.725,"askSize":50,"bidPrice":0.7,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.943378,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763389800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9206,"preHourTrading":{"tag":"盘前","latestPrice":0.7196,"preClose":0.9206,"latestTime":"07:50 EST","volume":19440,"amount":13795.432703999999,"timestamp":1763383838813},"postHourTrading":{"tag":"盘后","latestPrice":0.6734,"preClose":0.9206,"latestTime":"19:59 EST","volume":3297079,"amount":2414954.829073,"timestamp":1763168391160},"volumeRatio":21.18510736812188,"impliedVol":2.3584,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GTBP\",,,,,undefined,":{"symbol":"GTBP","floatShares":9262500,"roa":"-82.45%","roe":"-181.99%","lyrEps":-6.936952,"volumeRatio":21.18510736812188,"shares":10636135,"dividePrice":0,"high":1.15,"amplitude":0.606332,"preClose":0.7298,"low":0.707499,"week52Low":0.54,"pbRate":"3.42","week52High":4.1,"institutionHeld":0.0067,"latestPrice":0.9206,"committee":0.333333,"eps":-3.943378,"divideRate":0,"volume":13255009,"delay":0,"ttmEps":-3.943378,"open":0.7448,"prevYearClose":3.05,"prevWeekClose":0.9206,"prevMonthClose":0.6272,"prevQuarterClose":0.5865,"fiveDayClose":0.6195,"twentyDayClose":0.6914,"sixtyDayClose":1.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GTBP\",params:#limit:5,,,undefined,":[{"date":"2025-11-14","symbol":"GTBP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763110800000,"name":null,"time":"Pre-Market","dateTimestamp":1763096400000,"actualEps":null},{"market":"US","date":"2025-08-14","symbol":"GTBP","fiscalQuarterEnding":"2025/06","expectedEps":-0.68,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2025-02-21","symbol":"GTBP","fiscalQuarterEnding":"2024/12","expectedEps":-1.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740114000000,"reportTimeType":"post","actualEps":-1.66},{"market":"US","date":"2024-11-14","symbol":"GTBP","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-1.53},{"market":"US","date":"2024-08-14","symbol":"GTBP","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-2.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GTBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GTBP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1733374800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GTBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GTBP","date":"2025-11-14","current":-0.233455,"percent":0.978078,"low":-16.607296,"twenty":-2.564603,"median":-0.836081,"eighty":-0.50804,"high":-0.209588,"avg":-1.841076,"sd":2.222272,"marketCap":2596264},"quantilePoints":[{"date":"2020-11-20","current":-0.633457,"twenty":-0.040988,"median":-0.016302,"eighty":-0.003999,"marketCap":14871031},{"date":"2020-11-27","current":-0.583114,"twenty":-0.041408,"median":-0.016442,"eighty":-0.00404,"marketCap":13689175},{"date":"2020-12-04","current":-0.666797,"twenty":-0.041999,"median":-0.016559,"eighty":-0.004071,"marketCap":15653716},{"date":"2020-12-11","current":-0.881369,"twenty":-0.042861,"median":-0.016726,"eighty":-0.004088,"marketCap":20691008},{"date":"2020-12-18","current":-1.051113,"twenty":-0.043322,"median":-0.01696,"eighty":-0.004111,"marketCap":24675923},{"date":"2020-12-24","current":-2.045759,"twenty":-0.043667,"median":-0.017254,"eighty":-0.00414,"marketCap":48026227},{"date":"2020-12-31","current":-1.526386,"twenty":-0.044098,"median":-0.01732,"eighty":-0.004174,"marketCap":35833433},{"date":"2021-01-08","current":-1.830713,"twenty":-0.04484,"median":-0.017844,"eighty":-0.004174,"marketCap":42977809},{"date":"2021-01-15","current":-1.776146,"twenty":-0.053757,"median":-0.018318,"eighty":-0.004216,"marketCap":41696815},{"date":"2021-01-22","current":-1.704609,"twenty":-0.055994,"median":-0.018664,"eighty":-0.004217,"marketCap":40017395},{"date":"2021-01-29","current":-1.836848,"twenty":-0.058398,"median":-0.019115,"eighty":-0.004249,"marketCap":43121854},{"date":"2021-02-05","current":-1.739144,"twenty":-0.082028,"median":-0.020191,"eighty":-0.004278,"marketCap":40828139},{"date":"2021-02-12","current":-1.280506,"twenty":-0.083819,"median":-0.021608,"eighty":-0.004284,"marketCap":30061156},{"date":"2021-02-19","current":-1.296598,"twenty":-0.086321,"median":-0.022148,"eighty":-0.00429,"marketCap":30438944},{"date":"2021-02-26","current":-4.759823,"twenty":-0.155778,"median":-0.022319,"eighty":-0.004298,"marketCap":111741594},{"date":"2021-03-05","current":-4.476609,"twenty":-0.245072,"median":-0.022745,"eighty":-0.004309,"marketCap":105092862},{"date":"2021-03-12","current":-5.490697,"twenty":-0.250258,"median":-0.022745,"eighty":-0.004362,"marketCap":128899613},{"date":"2021-03-19","current":-6.020582,"twenty":-0.252192,"median":-0.022745,"eighty":-0.004395,"marketCap":141339176},{"date":"2021-03-26","current":-6.175893,"twenty":-0.257751,"median":-0.023549,"eighty":-0.004417,"marketCap":144985255},{"date":"2021-04-01","current":-6.568738,"twenty":-0.25951,"median":-0.023874,"eighty":-0.004431,"marketCap":154207690},{"date":"2021-04-09","current":-9.537917,"twenty":-0.268039,"median":-0.023882,"eighty":-0.004454,"marketCap":223912140},{"date":"2021-04-16","current":-9.874066,"twenty":-0.2721,"median":-0.024837,"eighty":-0.004489,"marketCap":279396566},{"date":"2021-04-23","current":-11.579951,"twenty":-0.27764,"median":-0.02502,"eighty":-0.004512,"marketCap":327666298},{"date":"2021-04-30","current":-13.295871,"twenty":-0.284149,"median":-0.025756,"eighty":-0.004552,"marketCap":376219970},{"date":"2021-05-07","current":-16.607296,"twenty":-0.288176,"median":-0.027466,"eighty":-0.004578,"marketCap":469920038},{"date":"2021-05-14","current":-12.362652,"twenty":-0.28988,"median":-0.028035,"eighty":-0.004606,"marketCap":349813587},{"date":"2021-05-21","current":-5.392234,"twenty":-0.297023,"median":-0.028117,"eighty":-0.004624,"marketCap":303394030},{"date":"2021-05-28","current":-6.473684,"twenty":-0.306023,"median":-0.028334,"eighty":-0.004656,"marketCap":364241858},{"date":"2021-06-04","current":-6.233362,"twenty":-0.318043,"median":-0.028603,"eighty":-0.004663,"marketCap":350720118},{"date":"2021-06-11","current":-6.759067,"twenty":-0.330403,"median":-0.029045,"eighty":-0.004687,"marketCap":380298924},{"date":"2021-06-18","current":-6.751557,"twenty":-0.344769,"median":-0.029539,"eighty":-0.004779,"marketCap":379876369},{"date":"2021-06-25","current":-5.441049,"twenty":-0.364174,"median":-0.029638,"eighty":-0.004791,"marketCap":306140633},{"date":"2021-07-02","current":-5.707657,"twenty":-0.388628,"median":-0.03025,"eighty":-0.004853,"marketCap":321141313},{"date":"2021-07-09","current":-5.5537,"twenty":-0.405818,"median":-0.030561,"eighty":-0.004932,"marketCap":312478949},{"date":"2021-07-16","current":-4.614941,"twenty":-0.409262,"median":-0.030626,"eighty":-0.00494,"marketCap":259659654},{"date":"2021-07-23","current":-4.483515,"twenty":-0.42041,"median":-0.03075,"eighty":-0.004943,"marketCap":252264952},{"date":"2021-07-30","current":-3.736262,"twenty":-0.427177,"median":-0.031021,"eighty":-0.005045,"marketCap":210220794},{"date":"2021-08-06","current":-4.171847,"twenty":-0.573778,"median":-0.03115,"eighty":-0.005048,"marketCap":234728946},{"date":"2021-08-13","current":-3.758792,"twenty":-0.590115,"median":-0.031417,"eighty":-0.005105,"marketCap":211488457},{"date":"2021-08-20","current":-2.842563,"twenty":-0.614953,"median":-0.031503,"eighty":-0.005269,"marketCap":159936825},{"date":"2021-08-27","current":-6.026134,"twenty":-0.633457,"median":-0.032012,"eighty":-0.005346,"marketCap":263366147},{"date":"2021-09-03","current":-5.844792,"twenty":-0.881369,"median":-0.032513,"eighty":-0.005483,"marketCap":255440777},{"date":"2021-09-10","current":-5.761095,"twenty":-0.949802,"median":-0.032558,"eighty":-0.005502,"marketCap":251782914},{"date":"2021-09-17","current":-5.433285,"twenty":-1.077565,"median":-0.032718,"eighty":-0.005576,"marketCap":237456283},{"date":"2021-09-24","current":-4.882284,"twenty":-1.328323,"median":-0.03324,"eighty":-0.005652,"marketCap":213375351},{"date":"2021-10-01","current":-4.617246,"twenty":-1.52075,"median":-0.033536,"eighty":-0.005725,"marketCap":201792117},{"date":"2021-10-08","current":-4.122043,"twenty":-1.560873,"median":-0.033536,"eighty":-0.005858,"marketCap":180149760},{"date":"2021-10-15","current":-4.219689,"twenty":-1.693467,"median":-0.03374,"eighty":-0.006249,"marketCap":184417267},{"date":"2021-10-22","current":-4.505651,"twenty":-1.723511,"median":-0.033945,"eighty":-0.006521,"marketCap":196914966},{"date":"2021-10-29","current":-4.505651,"twenty":-1.777335,"median":-0.033945,"eighty":-0.00662,"marketCap":196914966},{"date":"2021-11-05","current":-4.812537,"twenty":-1.793573,"median":-0.034516,"eighty":-0.006689,"marketCap":210327131},{"date":"2021-11-12","current":-3.401452,"twenty":-1.836156,"median":-0.034763,"eighty":-0.006965,"marketCap":157422621},{"date":"2021-11-19","current":-3.289389,"twenty":-1.87662,"median":-0.035069,"eighty":-0.007157,"marketCap":152236217},{"date":"2021-11-26","current":-2.920239,"twenty":-2.046326,"median":-0.035494,"eighty":-0.007223,"marketCap":135151591},{"date":"2021-12-03","current":-2.076468,"twenty":-2.491762,"median":-0.035581,"eighty":-0.007245,"marketCap":96101019},{"date":"2021-12-10","current":-2.208307,"twenty":-2.408703,"median":-0.036038,"eighty":-0.007313,"marketCap":102202671},{"date":"2021-12-17","current":-2.406066,"twenty":-2.374424,"median":-0.036307,"eighty":-0.007359,"marketCap":111355149},{"date":"2021-12-23","current":-2.45221,"twenty":-2.45221,"median":-0.036369,"eighty":-0.007359,"marketCap":113490727},{"date":"2021-12-31","current":-2.010548,"twenty":-2.433752,"median":-0.036779,"eighty":-0.007381,"marketCap":93050193},{"date":"2022-01-07","current":-2.109428,"twenty":-2.392882,"median":-0.036893,"eighty":-0.007438,"marketCap":97626432},{"date":"2022-01-14","current":-1.957813,"twenty":-2.370469,"median":-0.037012,"eighty":-0.007517,"marketCap":90609532},{"date":"2022-01-21","current":-1.74687,"twenty":-2.363877,"median":-0.037127,"eighty":-0.007585,"marketCap":80846889},{"date":"2022-01-28","current":-1.832565,"twenty":-2.346738,"median":-0.037216,"eighty":-0.007585,"marketCap":84812962},{"date":"2022-02-04","current":-1.753462,"twenty":-2.315724,"median":-0.037354,"eighty":-0.007585,"marketCap":81151971},{"date":"2022-02-11","current":-1.71391,"twenty":-2.293871,"median":-0.037571,"eighty":-0.007585,"marketCap":79321476},{"date":"2022-02-18","current":-1.924853,"twenty":-2.278182,"median":-0.03772,"eighty":-0.007585,"marketCap":89084119},{"date":"2022-02-25","current":-2.122612,"twenty":-2.267635,"median":-0.037838,"eighty":-0.007585,"marketCap":98236597},{"date":"2022-03-04","current":-2.036916,"twenty":-2.267635,"median":-0.037976,"eighty":-0.007592,"marketCap":94270523},{"date":"2022-03-11","current":-1.970997,"twenty":-2.228083,"median":-0.038168,"eighty":-0.007596,"marketCap":91219697},{"date":"2022-03-18","current":-1.990773,"twenty":-2.208307,"median":-0.038332,"eighty":-0.007663,"marketCap":92134945},{"date":"2022-03-25","current":-1.918261,"twenty":-2.175348,"median":-0.0385,"eighty":-0.007698,"marketCap":88779036},{"date":"2022-04-01","current":-1.611319,"twenty":-2.168756,"median":-0.038852,"eighty":-0.007698,"marketCap":93477476},{"date":"2022-04-08","current":-1.290163,"twenty":-2.162164,"median":-0.038925,"eighty":-0.007698,"marketCap":74846226},{"date":"2022-04-14","current":-1.406444,"twenty":-2.130522,"median":-0.038948,"eighty":-0.007747,"marketCap":81592023},{"date":"2022-04-22","current":-1.317446,"twenty":-2.122612,"median":-0.039057,"eighty":-0.007783,"marketCap":76429008},{"date":"2022-04-29","current":-1.203382,"twenty":-2.122612,"median":-0.039182,"eighty":-0.007822,"marketCap":69811778},{"date":"2022-05-06","current":-0.946736,"twenty":-2.112065,"median":-0.039271,"eighty":-0.00785,"marketCap":54923010},{"date":"2022-05-13","current":-1.100723,"twenty":-2.104154,"median":-0.0394,"eighty":-0.007879,"marketCap":63856271},{"date":"2022-05-20","current":-2.411088,"twenty":-2.122612,"median":-0.039518,"eighty":-0.007917,"marketCap":81436914},{"date":"2022-05-27","current":-2.537512,"twenty":-2.18194,"median":-0.039518,"eighty":-0.007925,"marketCap":85707014},{"date":"2022-06-03","current":-2.564603,"twenty":-2.24493,"median":-0.039552,"eighty":-0.007925,"marketCap":86622036},{"date":"2022-06-10","current":-2.627815,"twenty":-2.277708,"median":-0.03967,"eighty":-0.007925,"marketCap":88757086},{"date":"2022-06-17","current":-2.636845,"twenty":-2.350058,"median":-0.039736,"eighty":-0.007926,"marketCap":89062093},{"date":"2022-06-24","current":-2.691027,"twenty":-2.356906,"median":-0.039779,"eighty":-0.008012,"marketCap":90892136},{"date":"2022-07-01","current":-2.600724,"twenty":-2.402058,"median":-0.039913,"eighty":-0.008186,"marketCap":87842064},{"date":"2022-07-08","current":-2.663936,"twenty":-2.443986,"median":-0.039944,"eighty":-0.008265,"marketCap":89977115},{"date":"2022-07-15","current":-2.239513,"twenty":-2.478578,"median":-0.040209,"eighty":-0.008322,"marketCap":75641778},{"date":"2022-07-22","current":-2.799391,"twenty":-2.491762,"median":-0.040415,"eighty":-0.008349,"marketCap":94552222},{"date":"2022-07-29","current":-2.645876,"twenty":-2.5339,"median":-0.040497,"eighty":-0.008425,"marketCap":89367100},{"date":"2022-08-05","current":-2.519452,"twenty":-2.537512,"median":-0.040536,"eighty":-0.008461,"marketCap":85097000},{"date":"2022-08-12","current":-2.483331,"twenty":-2.546543,"median":-0.040709,"eighty":-0.008584,"marketCap":83876971},{"date":"2022-08-19","current":-2.632148,"twenty":-2.564603,"median":-0.041098,"eighty":-0.008605,"marketCap":83949744},{"date":"2022-08-26","current":-2.466421,"twenty":-2.580862,"median":-0.041389,"eighty":-0.008615,"marketCap":78664019},{"date":"2022-09-02","current":-2.476169,"twenty":-2.580862,"median":-0.041623,"eighty":-0.00865,"marketCap":78974944},{"date":"2022-09-09","current":-2.456672,"twenty":-2.573656,"median":-0.042052,"eighty":-0.008716,"marketCap":78353094},{"date":"2022-09-16","current":-1.978986,"twenty":-2.564603,"median":-0.042542,"eighty":-0.008717,"marketCap":63117770},{"date":"2022-09-23","current":-1.842504,"twenty":-2.564603,"median":-0.043137,"eighty":-0.008717,"marketCap":58764821},{"date":"2022-09-30","current":-1.715771,"twenty":-2.564603,"median":-0.04332,"eighty":-0.008717,"marketCap":54722796},{"date":"2022-10-07","current":-1.784012,"twenty":-2.563908,"median":-0.043667,"eighty":-0.008776,"marketCap":56899271},{"date":"2022-10-14","current":-1.803509,"twenty":-2.546543,"median":-0.043978,"eighty":-0.008802,"marketCap":57521121},{"date":"2022-10-21","current":-1.491551,"twenty":-2.546543,"median":-0.044161,"eighty":-0.008944,"marketCap":47571521},{"date":"2022-10-28","current":-1.891247,"twenty":-2.537512,"median":-0.044658,"eighty":-0.009057,"marketCap":60319446},{"date":"2022-11-04","current":-1.963898,"twenty":-2.537512,"median":-0.049794,"eighty":-0.009057,"marketCap":65441017},{"date":"2022-11-11","current":-2.081146,"twenty":-2.528482,"median":-0.05395,"eighty":-0.009062,"marketCap":69347943},{"date":"2022-11-18","current":-1.915045,"twenty":-2.524913,"median":-0.05578,"eighty":-0.009089,"marketCap":63813131},{"date":"2022-11-25","current":-1.788027,"twenty":-2.520544,"median":-0.057044,"eighty":-0.009089,"marketCap":59580627},{"date":"2022-12-02","current":-1.504678,"twenty":-2.519452,"median":-0.058978,"eighty":-0.009089,"marketCap":50138888},{"date":"2022-12-09","current":-1.494908,"twenty":-2.519452,"median":-0.081216,"eighty":-0.009089,"marketCap":49813311},{"date":"2022-12-16","current":-1.270183,"twenty":-2.516022,"median":-0.082763,"eighty":-0.009108,"marketCap":42325036},{"date":"2022-12-23","current":-1.065,"twenty":-2.51137,"median":-0.083819,"eighty":-0.009137,"marketCap":35487914},{"date":"2022-12-30","current":-0.865385,"twenty":-2.499585,"median":-0.083923,"eighty":-0.009154,"marketCap":28836372},{"date":"2023-01-06","current":-1.01946,"twenty":-2.499585,"median":-0.090304,"eighty":-0.009154,"marketCap":33970462},{"date":"2023-01-13","current":-0.946391,"twenty":-2.499585,"median":-0.244775,"eighty":-0.009154,"marketCap":31535642},{"date":"2023-01-20","current":-0.917027,"twenty":-2.499585,"median":-0.250258,"eighty":-0.009154,"marketCap":30557162},{"date":"2023-01-27","current":-0.829226,"twenty":-2.499585,"median":-0.252192,"eighty":-0.009154,"marketCap":27631477},{"date":"2023-02-03","current":-0.873126,"twenty":-2.499585,"median":-0.257994,"eighty":-0.009154,"marketCap":29094319},{"date":"2023-02-10","current":-0.829226,"twenty":-2.499585,"median":-0.265544,"eighty":-0.009154,"marketCap":27631477},{"date":"2023-02-17","current":-0.799862,"twenty":-2.499585,"median":-0.273009,"eighty":-0.009154,"marketCap":26652997},{"date":"2023-02-24","current":-0.634114,"twenty":-2.499585,"median":-0.277938,"eighty":-0.009154,"marketCap":21129953},{"date":"2023-03-03","current":-0.702403,"twenty":-2.499585,"median":-0.286659,"eighty":-0.009154,"marketCap":23405486},{"date":"2023-03-10","current":-0.546314,"twenty":-2.499585,"median":-0.288983,"eighty":-0.009154,"marketCap":18204267},{"date":"2023-03-17","current":-0.517144,"twenty":-2.499585,"median":-0.296697,"eighty":-0.009154,"marketCap":17232289},{"date":"2023-03-24","current":-0.610018,"twenty":-2.499585,"median":-0.306618,"eighty":-0.009154,"marketCap":20327014},{"date":"2023-03-31","current":-0.856119,"twenty":-2.495973,"median":-0.325048,"eighty":-0.009158,"marketCap":17879191},{"date":"2023-04-06","current":-0.863654,"twenty":-2.495973,"median":-0.339442,"eighty":-0.009158,"marketCap":18036542},{"date":"2023-04-14","current":-0.805489,"twenty":-2.499585,"median":-0.349783,"eighty":-0.009154,"marketCap":16821836},{"date":"2023-04-21","current":-0.740275,"twenty":-2.499585,"median":-0.388731,"eighty":-0.009154,"marketCap":15459893},{"date":"2023-04-28","current":-0.669772,"twenty":-2.499585,"median":-0.406197,"eighty":-0.009154,"marketCap":13987522},{"date":"2023-05-05","current":-0.530439,"twenty":-2.499585,"median":-0.418383,"eighty":-0.009154,"marketCap":11077682},{"date":"2023-05-12","current":-0.54631,"twenty":-2.503197,"median":-0.427071,"eighty":-0.009151,"marketCap":11409139},{"date":"2023-05-18","current":-0.507711,"twenty":-2.510421,"median":-0.464143,"eighty":-0.009143,"marketCap":10603038},{"date":"2023-05-26","current":-0.668865,"twenty":-2.51137,"median":-0.51734,"eighty":-0.009137,"marketCap":10481784},{"date":"2023-06-02","current":-0.588723,"twenty":-2.512318,"median":-0.52784,"eighty":-0.009131,"marketCap":9225879},{"date":"2023-06-09","current":-0.859969,"twenty":-2.513267,"median":-0.53859,"eighty":-0.009125,"marketCap":13476579},{"date":"2023-06-16","current":-0.835842,"twenty":-2.514215,"median":-0.550655,"eighty":-0.009119,"marketCap":13098486},{"date":"2023-06-23","current":-0.733363,"twenty":-2.516022,"median":-0.56635,"eighty":-0.009108,"marketCap":11492527},{"date":"2023-06-30","current":-0.713058,"twenty":-2.516879,"median":-0.578507,"eighty":-0.009103,"marketCap":11174330},{"date":"2023-07-06","current":-0.745068,"twenty":-2.516879,"median":-0.588723,"eighty":-0.009103,"marketCap":11675959},{"date":"2023-07-14","current":-0.671254,"twenty":-2.518594,"median":-0.604847,"eighty":-0.009094,"marketCap":10519219},{"date":"2023-07-21","current":-0.676509,"twenty":-2.519452,"median":-0.612069,"eighty":-0.009089,"marketCap":10601576},{"date":"2023-07-28","current":-0.669821,"twenty":-2.519452,"median":-0.616787,"eighty":-0.009089,"marketCap":10496758},{"date":"2023-08-04","current":-0.625867,"twenty":-2.519452,"median":-0.633457,"eighty":-0.009089,"marketCap":9807955},{"date":"2023-08-11","current":-0.794306,"twenty":-2.519452,"median":-0.644977,"eighty":-0.009089,"marketCap":11663590},{"date":"2023-08-18","current":-0.784896,"twenty":-2.519452,"median":-0.65931,"eighty":-0.009089,"marketCap":11525415},{"date":"2023-08-25","current":-0.744489,"twenty":-2.519452,"median":-0.668865,"eighty":-0.009089,"marketCap":10932076},{"date":"2023-09-01","current":-0.722348,"twenty":-2.519452,"median":-0.671254,"eighty":-0.009089,"marketCap":10606958},{"date":"2023-09-07","current":-0.830285,"twenty":-2.519452,"median":-0.675315,"eighty":-0.009089,"marketCap":12191906},{"date":"2023-09-13","current":-0.70851,"twenty":-2.519452,"median":-0.691904,"eighty":-0.009089,"marketCap":10403760},{"date":"2023-09-22","current":-0.686369,"twenty":-2.519452,"median":-0.697639,"eighty":-0.009089,"marketCap":10078642},{"date":"2023-09-29","current":-0.678066,"twenty":-2.519452,"median":-0.701269,"eighty":-0.009089,"marketCap":9956723},{"date":"2023-10-06","current":-0.657863,"twenty":-2.519452,"median":-0.701269,"eighty":-0.009089,"marketCap":9660053},{"date":"2023-10-13","current":-0.692734,"twenty":-2.519452,"median":-0.702403,"eighty":-0.009089,"marketCap":10172113},{"date":"2023-10-20","current":-0.666996,"twenty":-2.519452,"median":-0.702403,"eighty":-0.009089,"marketCap":9794164},{"date":"2023-11-03","current":-1.099941,"twenty":-2.522729,"median":-0.713058,"eighty":-0.009089,"marketCap":11240299},{"date":"2023-11-10","current":-0.993018,"twenty":-2.523821,"median":-0.715481,"eighty":-0.009089,"marketCap":10147654},{"date":"2023-11-17","current":-0.940328,"twenty":-2.525627,"median":-0.721716,"eighty":-0.009089,"marketCap":9609207},{"date":"2023-11-24","current":-0.981264,"twenty":-2.526341,"median":-0.722649,"eighty":-0.009089,"marketCap":10027539},{"date":"2023-11-30","current":-0.871424,"twenty":-2.527054,"median":-0.726851,"eighty":-0.009089,"marketCap":8905084},{"date":"2024-01-05","current":-1.037603,"twenty":-2.546543,"median":-0.763342,"eighty":-0.009306,"marketCap":10603263},{"date":"2024-01-12","current":-0.89169,"twenty":-2.546543,"median":-0.769181,"eighty":-0.009376,"marketCap":9112179},{"date":"2024-01-19","current":-0.895743,"twenty":-2.546543,"median":-0.783512,"eighty":-0.009443,"marketCap":9153598},{"date":"2024-01-26","current":-0.882773,"twenty":-2.546543,"median":-0.791879,"eighty":-0.009579,"marketCap":9021057},{"date":"2024-02-02","current":-0.753073,"twenty":-2.546543,"median":-0.796935,"eighty":-0.009742,"marketCap":7695650},{"date":"2024-02-09","current":-0.651203,"twenty":-2.546543,"median":-0.796935,"eighty":-0.010204,"marketCap":6654641},{"date":"2024-02-16","current":-0.553928,"twenty":-2.546543,"median":-0.796935,"eighty":-0.010563,"marketCap":5660587},{"date":"2024-02-23","current":-0.567046,"twenty":-2.546543,"median":-0.796935,"eighty":-0.010901,"marketCap":5794646},{"date":"2024-03-01","current":-0.57014,"twenty":-2.546543,"median":-0.79652,"eighty":-0.011487,"marketCap":5826262},{"date":"2024-03-08","current":-0.595351,"twenty":-2.546543,"median":-0.79652,"eighty":-0.0123,"marketCap":6083888},{"date":"2024-03-15","current":-0.636341,"twenty":-2.546543,"median":-0.79652,"eighty":-0.013517,"marketCap":6502772},{"date":"2024-03-22","current":-0.514747,"twenty":-2.546543,"median":-0.79652,"eighty":-0.014035,"marketCap":5260204},{"date":"2024-03-28","current":-0.794176,"twenty":-2.546543,"median":-0.79735,"eighty":-0.014257,"marketCap":6033357},{"date":"2024-04-05","current":-0.792814,"twenty":-2.546543,"median":-0.798672,"eighty":-0.014517,"marketCap":6023011},{"date":"2024-04-12","current":-0.726936,"twenty":-2.546543,"median":-0.798672,"eighty":-0.015031,"marketCap":5522532},{"date":"2024-04-19","current":-0.690607,"twenty":-2.546543,"median":-0.798672,"eighty":-0.015099,"marketCap":5246543},{"date":"2024-04-26","current":-0.681793,"twenty":-2.546543,"median":-0.797716,"eighty":-0.015354,"marketCap":5179582},{"date":"2024-05-03","current":-0.58064,"twenty":-2.546543,"median":-0.797716,"eighty":-0.015571,"marketCap":4411122},{"date":"2024-05-10","current":-0.58671,"twenty":-2.546543,"median":-0.797716,"eighty":-0.016115,"marketCap":4457235},{"date":"2024-05-17","current":-0.468521,"twenty":-2.546543,"median":-0.797716,"eighty":-0.01643,"marketCap":4514669},{"date":"2024-05-24","current":-0.558787,"twenty":-2.546543,"median":-0.799862,"eighty":-0.016698,"marketCap":5384468},{"date":"2024-05-31","current":-0.863914,"twenty":-2.546543,"median":-0.802521,"eighty":-0.017211,"marketCap":8324672},{"date":"2024-06-07","current":-0.734103,"twenty":-2.546543,"median":-0.804349,"eighty":-0.01796,"marketCap":7073815},{"date":"2024-06-14","current":-0.671436,"twenty":-2.546543,"median":-0.804714,"eighty":-0.019202,"marketCap":6469953},{"date":"2024-06-21","current":-0.637864,"twenty":-2.546543,"median":-0.80508,"eighty":-0.021653,"marketCap":6146455},{"date":"2024-06-28","current":-0.631149,"twenty":-2.553489,"median":-0.807553,"eighty":-0.022347,"marketCap":6081755},{"date":"2024-07-05","current":-0.615483,"twenty":-2.553489,"median":-0.807553,"eighty":-0.022745,"marketCap":5930790},{"date":"2024-07-12","current":-0.644578,"twenty":-2.553489,"median":-0.807553,"eighty":-0.023191,"marketCap":6211154},{"date":"2024-07-15","current":-0.655769,"twenty":-2.553489,"median":-0.807553,"eighty":-0.023596,"marketCap":6318987},{"date":"2024-08-02","current":-0.57072,"twenty":-2.564603,"median":-0.819471,"eighty":-0.243292,"marketCap":5499460},{"date":"2024-08-09","current":-0.492386,"twenty":-2.564603,"median":-0.819471,"eighty":-0.249225,"marketCap":4744632},{"date":"2024-08-16","current":-0.450173,"twenty":-2.564603,"median":-0.819471,"eighty":-0.252192,"marketCap":5111262},{"date":"2024-08-23","current":-0.425061,"twenty":-2.564603,"median":-0.819471,"eighty":-0.257842,"marketCap":4826148},{"date":"2024-08-30","current":-0.429745,"twenty":-2.564603,"median":-0.819471,"eighty":-0.265425,"marketCap":4879325},{"date":"2024-09-06","current":-0.405383,"twenty":-2.564603,"median":-0.819471,"eighty":-0.270001,"marketCap":4602715},{"date":"2024-09-13","current":-0.429017,"twenty":-2.564603,"median":-0.819471,"eighty":-0.277193,"marketCap":4871058},{"date":"2024-09-20","current":-0.409318,"twenty":-2.564603,"median":-0.819471,"eighty":-0.284685,"marketCap":4647402},{"date":"2024-09-27","current":-0.411286,"twenty":-2.564603,"median":-0.819471,"eighty":-0.288431,"marketCap":4669745},{"date":"2024-10-04","current":-0.413923,"twenty":-2.564603,"median":-0.819471,"eighty":-0.29576,"marketCap":4699685},{"date":"2024-10-11","current":-0.393575,"twenty":-2.564603,"median":-0.819471,"eighty":-0.30513,"marketCap":4468656},{"date":"2024-10-18","current":-0.415222,"twenty":-2.564603,"median":-0.819471,"eighty":-0.324957,"marketCap":4714432},{"date":"2024-10-25","current":-0.594299,"twenty":-2.564603,"median":-0.819471,"eighty":-0.33945,"marketCap":6747670},{"date":"2024-10-31","current":-0.592331,"twenty":-2.564603,"median":-0.819471,"eighty":-0.349783,"marketCap":6725327},{"date":"2024-11-08","current":-0.610042,"twenty":-2.564603,"median":-0.821549,"eighty":-0.388106,"marketCap":6926416},{"date":"2024-11-15","current":-0.592331,"twenty":-2.564603,"median":-0.821549,"eighty":-0.393575,"marketCap":6725327},{"date":"2024-11-22","current":-0.544605,"twenty":-2.564603,"median":-0.821549,"eighty":-0.398654,"marketCap":6725327},{"date":"2024-11-29","current":-0.506609,"twenty":-2.564603,"median":-0.821549,"eighty":-0.404989,"marketCap":6256118},{"date":"2024-12-06","current":-0.448928,"twenty":-2.564603,"median":-0.821549,"eighty":-0.406761,"marketCap":5543814},{"date":"2024-12-13","current":-0.495753,"twenty":-2.564603,"median":-0.821549,"eighty":-0.410105,"marketCap":6122058},{"date":"2024-12-20","current":-0.347389,"twenty":-2.564603,"median":-0.821549,"eighty":-0.413693,"marketCap":4289909},{"date":"2024-12-27","current":-0.55908,"twenty":-2.564603,"median":-0.821549,"eighty":-0.416243,"marketCap":6904073},{"date":"2025-01-03","current":-0.53194,"twenty":-2.564603,"median":-0.821549,"eighty":-0.418144,"marketCap":6568924},{"date":"2025-01-10","current":-0.461376,"twenty":-2.564603,"median":-0.823628,"eighty":-0.422307,"marketCap":5697536},{"date":"2025-01-17","current":-0.421571,"twenty":-2.564603,"median":-0.823628,"eighty":-0.425138,"marketCap":5205984},{"date":"2025-01-24","current":-0.430618,"twenty":-2.564603,"median":-0.823628,"eighty":-0.426781,"marketCap":5317700},{"date":"2025-01-31","current":-0.37272,"twenty":-2.564603,"median":-0.823628,"eighty":-0.427003,"marketCap":4602715},{"date":"2025-02-07","current":-0.396241,"twenty":-2.564603,"median":-0.823628,"eighty":-0.427003,"marketCap":4893178},{"date":"2025-02-14","current":-0.405287,"twenty":-2.564603,"median":-0.823628,"eighty":-0.427003,"marketCap":5004894},{"date":"2025-02-21","current":-0.385385,"twenty":-2.564603,"median":-0.823628,"eighty":-0.427003,"marketCap":4759118},{"date":"2025-02-28","current":-0.390439,"twenty":-2.564603,"median":-0.823628,"eighty":-0.427003,"marketCap":5138954},{"date":"2025-03-07","current":-0.402322,"twenty":-2.564603,"median":-0.823883,"eighty":-0.427088,"marketCap":5295357},{"date":"2025-03-14","current":-0.420995,"twenty":-2.564603,"median":-0.823883,"eighty":-0.427088,"marketCap":5541133},{"date":"2025-03-21","current":-0.383648,"twenty":-2.564603,"median":-0.823883,"eighty":-0.427177,"marketCap":5049581},{"date":"2025-03-28","current":-0.390439,"twenty":-2.564603,"median":-0.823883,"eighty":-0.427177,"marketCap":5138954},{"date":"2025-04-04","current":-0.395531,"twenty":-2.564603,"median":-0.823883,"eighty":-0.427177,"marketCap":5205984},{"date":"2025-04-11","current":-0.392136,"twenty":-2.564603,"median":-0.823628,"eighty":-0.427118,"marketCap":5161297},{"date":"2025-04-17","current":-0.381951,"twenty":-2.564603,"median":-0.823628,"eighty":-0.427118,"marketCap":5027238},{"date":"2025-04-25","current":-0.387366,"twenty":-2.564603,"median":-0.823883,"eighty":-0.427177,"marketCap":5098513},{"date":"2025-05-02","current":-0.47213,"twenty":-2.564603,"median":-0.823883,"eighty":-0.429005,"marketCap":6214172},{"date":"2025-05-09","current":-0.450932,"twenty":-2.564603,"median":-0.823883,"eighty":-0.432427,"marketCap":5935168},{"date":"2025-05-16","current":-0.431662,"twenty":-2.564603,"median":-0.823883,"eighty":-0.435493,"marketCap":5681529},{"date":"2025-05-23","current":-0.580207,"twenty":-2.564603,"median":-0.823883,"eighty":-0.440765,"marketCap":6772179},{"date":"2025-05-30","current":-0.586726,"twenty":-2.564603,"median":-0.823883,"eighty":-0.442953,"marketCap":6848271},{"date":"2025-06-06","current":-0.598603,"twenty":-2.564603,"median":-0.823883,"eighty":-0.448959,"marketCap":6986892},{"date":"2025-06-13","current":-0.624883,"twenty":-2.564603,"median":-0.823883,"eighty":-0.452215,"marketCap":7293639},{"date":"2025-06-20","current":-0.792932,"twenty":-2.564603,"median":-0.824137,"eighty":-0.458916,"marketCap":9255105},{"date":"2025-06-27","current":-1.024878,"twenty":-2.564603,"median":-0.830285,"eighty":-0.468319,"marketCap":11962381},{"date":"2025-07-03","current":-0.753825,"twenty":-2.564603,"median":-0.836081,"eighty":-0.476772,"marketCap":8798646},{"date":"2025-07-11","current":-0.617624,"twenty":-2.564603,"median":-0.836081,"eighty":-0.486826,"marketCap":7208908},{"date":"2025-07-18","current":-0.547501,"twenty":-2.564603,"median":-0.836081,"eighty":-0.496115,"marketCap":6390429},{"date":"2025-07-25","current":-0.577168,"twenty":-2.564603,"median":-0.836081,"eighty":-0.506609,"marketCap":6736709},{"date":"2025-08-01","current":-0.501651,"twenty":-2.564603,"median":-0.836081,"eighty":-0.50804,"marketCap":5855270},{"date":"2025-08-08","current":-0.49356,"twenty":-2.564603,"median":-0.836081,"eighty":-0.50804,"marketCap":5760830},{"date":"2025-08-15","current":-0.391072,"twenty":-2.564603,"median":-0.836081,"eighty":-0.50804,"marketCap":4564592},{"date":"2025-08-22","current":-0.405165,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":3806527},{"date":"2025-08-29","current":-0.366315,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":3441527},{"date":"2025-09-05","current":-0.351774,"twenty":-2.564603,"median":-0.836824,"eighty":-0.510228,"marketCap":3304919},{"date":"2025-09-12","current":-0.282101,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":2650338},{"date":"2025-09-19","current":-0.308872,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":2901854},{"date":"2025-09-26","current":-0.28816,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":2707259},{"date":"2025-10-03","current":-0.241925,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":2272888},{"date":"2025-10-10","current":-0.284411,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":2672039},{"date":"2025-10-17","current":-0.258245,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":2426216},{"date":"2025-10-24","current":-0.2768,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":2600533},{"date":"2025-10-31","current":-0.23776,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":2233755},{"date":"2025-11-07","current":-0.209588,"twenty":-2.564603,"median":-0.836081,"eighty":-0.509531,"marketCap":1969077},{"date":"2025-11-14","current":-0.276345,"twenty":-2.564603,"median":-0.836081,"eighty":-0.50804,"marketCap":2596264}],"updateTime":1763373025065},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GTBP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583501068","title":"GT Biopharma Inc: Holds $2.6M Cash and Cash Equivalents as of Sept 30, Funding Operations Through Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2583501068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583501068?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:00","pubTimestamp":1763128802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nTUA3WFMPP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2583059501","title":"GT Biopharma Inc: Anticipates Submission of Ind Application for Gtb-5550 in Late December 2025 or in January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2583059501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583059501?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:00","pubTimestamp":1763128802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nTUA3WFMPP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2578540540","title":"GT Biopharma files to sell 14.59M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2578540540","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578540540?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:20","pubTimestamp":1761337216,"startTime":"0","endTime":"0","summary":"16:17 EDT GT Biopharma (GTBP) files to sell 14.59M shares of common stock for holders Published first on TheFly – the ultimate source for real-time...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gt-biopharma-files-to-sell-14-59m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gt-biopharma-files-to-sell-14-59m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GTBP","BK4139","GT","BK4585","BK4119"],"gpt_icon":0},{"id":"2577302020","title":"BRIEF-GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies","url":"https://stock-news.laohu8.com/highlight/detail?id=2577302020","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577302020?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:07","pubTimestamp":1761224842,"startTime":"0","endTime":"0","summary":"BRIEF-GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic MalignanciesOct 23 (Reuters) - GT Biopharma Inc GTBP.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUA1NKLJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2577530243","title":"GT Biopharma Provides Enrollment Update on Gtb-3650 Phase 1 Trial in Patients With Relapsed or Refractory (R/R) Cd33 Expressing Hematologic Malignancies","url":"https://stock-news.laohu8.com/highlight/detail?id=2577530243","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577530243?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:00","pubTimestamp":1761224405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUA1NKLJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2577234302","title":"GT Biopharma Inc - Screening Patients for Cohort 4, Dosing to Start Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2577234302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577234302?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:00","pubTimestamp":1761224405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUA1NKLJW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2577230223","title":"GT Biopharma Inc - Advances to Cohort 4 With 10 Ug/Kg/Day Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2577230223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577230223?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:00","pubTimestamp":1761224405,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUA1NKLJW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2577022393","title":"GT Biopharma Inc - Next Update Expected in Q1 2026 With Dose Escalation","url":"https://stock-news.laohu8.com/highlight/detail?id=2577022393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577022393?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:00","pubTimestamp":1761224405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUA1NKLJW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2573925095","title":"GT Biopharma Provides Enrollment Update on Gtb-3650 Phase 1 Trial in Patients With Relapsed or Refractory (R/R) Cd33 Expressing Hematologic Malignancies","url":"https://stock-news.laohu8.com/highlight/detail?id=2573925095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573925095?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:00","pubTimestamp":1759928402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUABJVDMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2573263229","title":"GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies","url":"https://stock-news.laohu8.com/highlight/detail?id=2573263229","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573263229?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:00","pubTimestamp":1759928400,"startTime":"0","endTime":"0","summary":"The Company is well on track with Phase 1 enrollment now that both patients in Cohort 3 have successfully initiated treatment with no evidence of dose-limiting toxicities or tolerability concerns to d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/08/3163394/0/en/GT-Biopharma-Provides-Enrollment-Update-on-GTB-3650-Phase-1-Trial-in-Patients-with-Relapsed-or-Refractory-r-r-CD33-Expressing-Hematologic-Malignancies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GTBP","BK4585","BK4119","BK4139","GT"],"gpt_icon":0},{"id":"2573677773","title":"GT Biopharma to Participate in the Centurion One Capital 3rd Annual Bahamas Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2573677773","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573677773?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:00","pubTimestamp":1759755600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, CALIFORNIA, Oct.  06, 2025  (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/06/3161768/0/en/GT-Biopharma-to-Participate-in-the-Centurion-One-Capital-3rd-Annual-Bahamas-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","GTBP","GT","BK4588","BK4211","SMMF","BK4119"],"gpt_icon":0},{"id":"2570832998","title":"GT Biopharma Preferred Shareholders Waive Redemption Rights on Series L Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2570832998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570832998?lang=en_us&edition=fundamental","pubTime":"2025-09-27 04:20","pubTimestamp":1758918036,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc. has announced that all holders of its Series L 10% Convertible Preferred Stock have agreed to waive their rights to redemption as provided in the stock's certificate of designation. The waivers, received from holders on several dates in September 2025, mean that Series L Preferred Stockholders will no longer be able to require the company to redeem their shares under the previously established terms. This modification impacts the rights of security holders and alters the conditions under which the preferred shares may be repaid or converted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GT Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL707dpv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2569974994","title":"GT Biopharma Inc. Announces Waiver of Redemption Rights for Series L Preferred Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2569974994","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569974994?lang=en_us&edition=fundamental","pubTime":"2025-09-24 05:31","pubTimestamp":1758663087,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc. has announced a significant development regarding its Series L 10% Convertible Preferred Stock. The company reported that on September 17, 18, and 23, 2025, certain holders of this preferred stock provided a waiver to the Certificate of Designation, agreeing to forgo their rights to redemption as outlined in Section 10 of the document. This waiver represents a material modification to the rights of these security holders, allowing GT Biopharma greater flexibility in managing its financial obligations related to the Series L Preferred Stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GT Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL90f46z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2563071046","title":"GT Biopharma Inc. Renews CEO Michael Breen's Contract for Additional Two Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2563071046","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563071046?lang=en_us&edition=fundamental","pubTime":"2025-08-30 04:16","pubTimestamp":1756498577,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc. announced a management change with the renewal of Michael Breen's position as Chief Executive Officer. The company's Board of Directors has extended Mr. Breen's term for an additional two years, starting from April 29, 2025. His employment will continue to automatically renew for subsequent two-year periods unless either party provides a ninety-day written notice of non-renewal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GT Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL18h3rH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2559640179","title":"GT Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559640179","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559640179?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:48","pubTimestamp":1755204503,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc reports results for the quarter ended June 30 - Earnings SummaryGT Biopharma Inc GTBP.OQ reported a quarterly adjusted loss of 52 cents per share for the quarter ended June 30.  The l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nL8N3U61NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP"],"gpt_icon":0},{"id":"2559762964","title":"GT Biopharma Q2 EPS $(0.55) Beats $(0.68) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559762964","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559762964?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:42","pubTimestamp":1755204154,"startTime":"0","endTime":"0","summary":"GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.68) by 19.12 percent. This is a 74.65 percent increase over losses of $(2.17) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47140505/gt-biopharma-q2-eps-0-55-beats-0-68-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","GT"],"gpt_icon":0},{"id":"2559617359","title":"GT Biopharma Inc: Q2 Net Loss About $1.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2559617359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559617359?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nTUA4KNDPP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2559646829","title":"GT Biopharma Reports Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2559646829","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559646829?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201900,"startTime":"0","endTime":"0","summary":"GTB-3650 TriKEPhase 1 trial has successfully completed Cohort 1 and Cohort 2 dosing, treating a total of four patients; following Cohort 2’s formal safety review, it has advanced into Cohort 3 and ini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/14/3133848/0/en/GT-Biopharma-Reports-Second-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4119","BK4139","GT","GTBP","BK4585","BK4588"],"gpt_icon":0},{"id":"2558365432","title":"GT Biopharma Inc - to Release Initial Phase 1 Results in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2558365432","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558365432?lang=en_us&edition=fundamental","pubTime":"2025-08-11 19:00","pubTimestamp":1754910000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nTUA59Z5YW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2558675652","title":"GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2558675652","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558675652?lang=en_us&edition=fundamental","pubTime":"2025-08-11 19:00","pubTimestamp":1754910000,"startTime":"0","endTime":"0","summary":"The first patient in Cohort 3, the fifth patient in the trial, has completed the first week of cycle 1 following the successful safety review of Cohort 2 with no safety or tolerability issues observed","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/11/3130758/0/en/GT-Biopharma-Advances-into-Cohort-3-of-GTB-3650-Phase-1-Trial-Following-Safety-Review-of-Cohort-2.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4119","GT","GTBP","BK4585","BK4139","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}